Edwin Tucker
Chief Tech/Sci/R&D Officer presso JASPER THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Edwin J.
Tucker currently works at The Royal College of Physicians, as Member and Jasper Therapeutics, Inc., as Chief Medical Officer from 2023.
Dr. Tucker also formerly worked at Genentech, Inc., as Vice President-Global Safety from 2013 to 2015, Johnson & Johnson, as Vice President-Global Safety from 2010 to 2013, Goldfinch Bio, Inc., as Chief Medical Officer, Mirum Pharmaceuticals, Inc., as Chief Medical Officer from 2019 to 2021, and Acerta Pharma LLC, as Chief Operating Officer from 2018 to 2019.
Dr. Tucker received his doctorate degree from the University of Leeds and Masters Business Admin degree from the University of Connecticut.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
15/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Edwin Tucker
Società | Posizione | Inizio |
---|---|---|
JASPER THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 12/06/2023 |
The Royal College of Physicians | Corporate Officer/Principal | - |
Precedenti posizioni note di Edwin Tucker
Società | Posizione | Fine |
---|---|---|
MIRUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2021 |
Acerta Pharma LLC | Compliance Officer | 01/01/2018 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2015 |
JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2013 |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
Formazione di Edwin Tucker
University of Leeds | Doctorate Degree |
University of Connecticut | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
JOHNSON & JOHNSON | Health Technology |
MIRUM PHARMACEUTICALS, INC. | Health Technology |
JASPER THERAPEUTICS, INC. | Finance |
Aziende private | 3 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
Acerta Pharma LLC |
- Borsa valori
- Insiders
- Edwin Tucker